An immunologist found by a former employer to have committed misconduct in more than 20 papers has had another paper retracted.
Here’s the notice for “Refining siRNA in vivo transfection: Silencing SPHK1 reveals its key role in C5a-induced inflammation in vivo,” by Alirio Melendez and colleagues in The International Journal of Biochemistry & Cell Biology: Continue reading Retraction nine appears for Alirio Melendez
The journal Inorganica Chimica Acta has retracted a paper it published earlier this year over an authorship dispute involving the lead researcher and his colleagues in France.
The title of the paper — whose bulk alone gave us a headache — was “Reaction of a bidentate ligands (4,4′-dimethyl 2,2′-bipyridine) with planar-chiral chloro-bridged ruthenium: Synthesis of cis-dicarbonyl[4,4′-dimethyl-2,2′-bipyridine- κO1,κO2]{2-[tricarbonyl(η6-phenylene- κC1)chromium]pyridine-κN}ruthenium hexafluorophosphate” — and it purportedly came from a lab in Beirut.
However, as the retraction notice indicates, that’s not quite so:
Continue reading Paper — with longest title ever? — retracted for lack of author approval
In a new retraction notice, the Journal of Controlled Release is living up to its name.
The editor-in-chief has retracted a study that plagiarized “a large number” of papers, but only three are listed in the notice. Here’s the notice for “In situ-forming hydrogels for sustained ophthalmic drug delivery,” by Basavaraj K. Nanjawade, F.V. Manvi, and A.S. Manjappa, three researchers at India’s KLES’s College of Pharmacy, JN Medical College Campus, Karnataka: Continue reading Study plagiarizes so many other papers, retraction notice can’t list them all
Noriyuki Takai, a gynecologic cancer researcher at Oita University in Japan who retracted three papers last October, has four more retractions, these in Cancer Letters.
All but one of the notices reads as follows: Continue reading Retraction count for gynecologic cancer researcher Takai grows to seven
Let’s say you’re a researcher who’s just gotten reviews back from your latest manuscript, asking for some revisions. Luckily, you find yourself at a conference and spot a presentation that’s related to your work. So you use a bunch of that presentation material in your paper.
Unfortunately for you, the guy who gave that conference presentation sees your paper when it’s published — and he’s justifiably unhappy enough to contact the editors. Continue reading Need more material for your paper under review? Just take it from someone else’s conference presentation
A Saudi engineer has lost his 2012 paper in Renewable and Sustainable Energy Reviews for plagiarizing from two previously published articles, including one in the same journal.
The article, titled “Fresh water production from/by atmospheric air for arid regions, using solar energy: Review,” was written by A.M.K. El-Ghonemy, of Al-Jouf University.
According to the retraction notice:
Continue reading Fresh water paper proves recycled, gets retracted
Sanjeeb K. Sahoo, of the Institute of Life Sciences in Bhubaneswar, India, has had four papers retracted from Acta Biomaterialia for what the journal is calling “highly unethical practices.”
All four notices say the same thing: Continue reading “Highly unethical practices” force four retractions for nanotech researcher
A University of Minnesota social scientist who studies health disparities has retracted a study that apparently lacked ethical approval.
Here’s the notice for “Deservingness to state health services for South – South migrants: A preliminary study of Costa Rican providers’ views,” a paper in Social Science & Medicine by Kate Goldade and a colleague: Continue reading Social sciences paper retracted for lack of ethical approval
Earlier today, we reported on the withdrawal of a paper from Research Policy, an Elsevier journal. The notice didn’t give a reason, just that the “article has been withdrawn at the request of the authors and editor.”
We’ve seen a number of such opaque withdrawals from Elsevier journals, and thought it was worth some exploration. While Elsevier’s policy here on such withdrawals is clear, as it is in other matters, we take some issue with it: Continue reading Is an “article in press” “published?” A word about Elsevier’s withdrawal policy
A frequent co-author of Ulrich Lichtenthaler — the management professor who has retracted at least eight papers — has now withdrawn one of his own from Research Policy.
The original paper, “How to create commercial value from patents: The role of patent management,” by Holger Ernst and colleagues, went online on May 21, 2012. Here’s the notice: Continue reading Lichtenthaler co-author Ernst retracts paper that didn’t include Lichtenthaler